UK startup unveils AI-designed cancer immunotherapy
Summary A UK startup has unveiled one of the first generative AI-designed immunotherapy candidates, created to target a protein found in many cancers. UK biotech startup Etcembly has used generative AI to design a novel cancer immunotherapy in record time. According to the company, its technology enables the rapid generation and optimization of T cell …
UK startup unveils AI-designed cancer immunotherapy Read More »